Arcutis Biotherapeutics, Inc. Common Stock (NASDAQ: ARQT) last traded at $25.08, down 1.07% on the session. The quote above updates while this page is open; the figures below are drawn from Arcutis Biotherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Arcutis Biotherapeutics, Inc. Common Stock trades on NASDAQ under the ticker ARQT. Its market capitalisation is $3.15 billion.
Valuation measures for Arcutis Biotherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.15B |
|---|---|
| Enterprise value | $3.39B |
| P/E ratio | 114.00 |
| Price / sales | 6.79 |
| Price / book | 14.29 |
| Beta | 1.14 |
Trailing-twelve-month figures tagged in Arcutis Biotherapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $463.98M |
|---|---|
| Net income (TTM) | $28.52M |
| EPS (TTM) | $0.220 |
| Operating margin | 7.38% |
| Return on equity | 12.93% |
| Cash | $34.12M |
Range and volume for ARQT over the past 52 weeks.
| 52-week high | $31.77 |
|---|---|
| 52-week low | $15.10 |
| Volume | 2.16M |
| Average volume | 1.68M |
| Previous close | $25.35 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.